Gapping up
In reaction to strong earnings/guidance: RATE +29.3%, MB +17.7%, ZEN +17.4%, RLOC +15.6%, USNA +15.1%, ( announced BoDs appointed Dave Wentz and Kevin Guest as Co-Chief Executive Officers effective immediately), SCMP +13.5%, ECOM +13.4%, CHUY +12.3%, Z +11.7%, ACLS +9.8%, FSLR +9.7%, ZAGG +8.1%, PLPM +8.1%, OCLR +7.5%, SCMP+7.5%, AWAY +7.3%, PAYC +6.9%, ATVI +6.9%, TSEM +6.9%, SMCI +6.6%, OFIX +6.4%, OFIX +6.4%, TTOO +6.3%, COKE +6.1%, KATE +6%, LC +5.9%, AMSG +5.8%, MSI +5.6%, GNRT +5.2%, WD +5.2%, REXX +5.1%, SPNS +4.7%, ENPH +4.6%, OXGN +4.5%, DNOW +4.4%, AHS +4.2%, RMTI +4%, RTRX +4%, XXIA +3.9%, EYES +3.7%, OAS +3.6%, TSE+3.1%, RDC +2.9%, SYNC +2.5%, CSV +1.8%, UVE +1.6%, CDE +1.5%, CWEI +1.3%, TROX +1.2%, ACHC +1.2%, HZN +1.2%, TRUP +1%, RLH +1%, BXE +1%, PRGO +1%, DVN +0.9%, ATHM +0.9%, DVA +0.7%
M&A news: MSI +7.8% (Silver Lake planning $1 bln investment in MSI, according to NY Times Dealbook; also reported earnings ), SCTY +2% (to acquire ILIOSS, to expand into Mexico)
Select metals/mining stocks trading higher: CLF +4.5%, VALE +2.7%, FCX +2.3%, GOLD +1.9%
Select oil/gas related names showing strength: SDRL +3.9%, LINE +3.8%, RDS.A +1.3%, TOT +1.0%, BP +0.9%
Other news: BIOC +10.5% (announced the launch of its proprietary quantitative Target Selector assay targeting KRAS mutations utilizing a patient's blood sample), ARRY +7.9% (mentioned positively by Jim Cramer), ATEN +6.9% (disclosed that on June 5, 2015, Founder and CEO Lee Chen entered into a written stock trading plan in accordance with Rule 10b5-1 to purchase up to an aggregate of $2 mln of common stock), LC +5.9% ( announces a 43.75 mln share public offering of common stock), ADAT +4.6% (disclosed it will explore strategic and financial alternatives in an effort to enhance shareholder value), AAC +3.8% (Chairman and CEO Michael Cartwright disclosed the purchase of 16.66k shares for ~$343k; Director Darrell Freeman purchases 15k shares for $331k), SPWR +3% (in sympathy with FSLR after earnings), JKS +2.8% (in sympathy with FSLR after earnings), SUNE +2.4% (in sympathy with FSLR after earnings), EA +1.7% (in symp with ATVI earnings), PLUG +1.1% (Axane S.A. (L'Aire Liquide) disclosed 5.64% active stake in 13D filing) SNSS +0.7% (announces that results from its Phase 3 VALOR trial of vosaroxin and cytarabine were published in The Lancet Oncology)
Analyst comments: BHP +4.6% (upgraded to Hold at Liberum), RIO +4.2% (upgraded to Hold at Liberum ), JCP +0.7% (upgraded to Hold from Sell at Evercore ISI
)
In reaction to strong earnings/guidance: RATE +29.3%, MB +17.7%, ZEN +17.4%, RLOC +15.6%, USNA +15.1%, ( announced BoDs appointed Dave Wentz and Kevin Guest as Co-Chief Executive Officers effective immediately), SCMP +13.5%, ECOM +13.4%, CHUY +12.3%, Z +11.7%, ACLS +9.8%, FSLR +9.7%, ZAGG +8.1%, PLPM +8.1%, OCLR +7.5%, SCMP+7.5%, AWAY +7.3%, PAYC +6.9%, ATVI +6.9%, TSEM +6.9%, SMCI +6.6%, OFIX +6.4%, OFIX +6.4%, TTOO +6.3%, COKE +6.1%, KATE +6%, LC +5.9%, AMSG +5.8%, MSI +5.6%, GNRT +5.2%, WD +5.2%, REXX +5.1%, SPNS +4.7%, ENPH +4.6%, OXGN +4.5%, DNOW +4.4%, AHS +4.2%, RMTI +4%, RTRX +4%, XXIA +3.9%, EYES +3.7%, OAS +3.6%, TSE+3.1%, RDC +2.9%, SYNC +2.5%, CSV +1.8%, UVE +1.6%, CDE +1.5%, CWEI +1.3%, TROX +1.2%, ACHC +1.2%, HZN +1.2%, TRUP +1%, RLH +1%, BXE +1%, PRGO +1%, DVN +0.9%, ATHM +0.9%, DVA +0.7%
M&A news: MSI +7.8% (Silver Lake planning $1 bln investment in MSI, according to NY Times Dealbook; also reported earnings ), SCTY +2% (to acquire ILIOSS, to expand into Mexico)
Select metals/mining stocks trading higher: CLF +4.5%, VALE +2.7%, FCX +2.3%, GOLD +1.9%
Select oil/gas related names showing strength: SDRL +3.9%, LINE +3.8%, RDS.A +1.3%, TOT +1.0%, BP +0.9%
Other news: BIOC +10.5% (announced the launch of its proprietary quantitative Target Selector assay targeting KRAS mutations utilizing a patient's blood sample), ARRY +7.9% (mentioned positively by Jim Cramer), ATEN +6.9% (disclosed that on June 5, 2015, Founder and CEO Lee Chen entered into a written stock trading plan in accordance with Rule 10b5-1 to purchase up to an aggregate of $2 mln of common stock), LC +5.9% ( announces a 43.75 mln share public offering of common stock), ADAT +4.6% (disclosed it will explore strategic and financial alternatives in an effort to enhance shareholder value), AAC +3.8% (Chairman and CEO Michael Cartwright disclosed the purchase of 16.66k shares for ~$343k; Director Darrell Freeman purchases 15k shares for $331k), SPWR +3% (in sympathy with FSLR after earnings), JKS +2.8% (in sympathy with FSLR after earnings), SUNE +2.4% (in sympathy with FSLR after earnings), EA +1.7% (in symp with ATVI earnings), PLUG +1.1% (Axane S.A. (L'Aire Liquide) disclosed 5.64% active stake in 13D filing) SNSS +0.7% (announces that results from its Phase 3 VALOR trial of vosaroxin and cytarabine were published in The Lancet Oncology)
Analyst comments: BHP +4.6% (upgraded to Hold at Liberum), RIO +4.2% (upgraded to Hold at Liberum ), JCP +0.7% (upgraded to Hold from Sell at Evercore ISI
)